Global Ankylosing Spondylitis Market and Competitive Landscape – 2017

Best Price Guarantee	Publisher	Published Date	SKU
from $3,990	Fore Pharma	August, 2017	FPCI15450552

Best Price Guarantee
Price	from $3,990
Publisher	Fore Pharma
Published Date	August, 2017
SKU	FPCI15450552

Global Ankylosing Spondylitis Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Ankylosing Spondylitis Market and Competitive Landscape – 2017, provides comprehensive insights into Ankylosing Spondylitis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Ankylosing Spondylitis market size and drug sales. This research also provides insights into Ankylosing Spondylitis epidemiology and late stage pipeline.
The report is classified into twelve sections – Ankylosing Spondylitis overview with definitions, symptoms, etiology, diagnosis, treatment options; Ankylosing Spondylitis pipeline insights covering late stage clinical trials pipeline; Ankylosing Spondylitis prevalence trends by countries; Ankylosing Spondylitis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

Ankylosing Spondylitis pipeline: Find out the drugs in clinical trials for Ankylosing Spondylitis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
Ankylosing Spondylitis epidemiology: Find out the prevalence of Ankylosing Spondylitis by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
Ankylosing Spondylitis products: Identify key products marketed and prescribed for Ankylosing Spondylitis by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Ankylosing Spondylitis market size: Find out the market size for Ankylosing Spondylitis drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
Ankylosing Spondylitis drug sales: Find out the sales of Ankylosing Spondylitis drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
Ankylosing Spondylitis drugs sales forecast: Sales forecast for Ankylosing Spondylitis drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Ankylosing Spondylitis market share analysis: Find out the market shares of Ankylosing Spondylitis drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

Evaluate commercial market opportunities for Ankylosing Spondylitis drugs
Synthesize insights for business development & licensing
Track market size, competitor drug sales, market shares in Ankylosing Spondylitis market
Develop in-depth knowledge of competition and markets
Analyze sales data to update your brand planning trackers
Develop tactics and strategies to take advantage of opportunities in the market
Track market trends and analyze key events in Ankylosing Spondylitis market
Develop forecast models, healthcare frameworks, or economic models
Answer key business questions; supports decision making in R&D to long term marketing strategies

1. Ankylosing Spondylitis: Disease Overview: 1.1. Ankylosing Spondylitis Symptoms; 1.2. Ankylosing Spondylitis Etiology; 1.3. Ankylosing Spondylitis Diagnosis; 1.4. Ankylosing Spondylitis Treatment Options
2. Ankylosing Spondylitis Pipeline Insights: 2.1. Ankylosing Spondylitis Phase 3 Clinical Trials; 2.2. Ankylosing Spondylitis Phase 2 Clinical Trials; 2.3. Ankylosing Spondylitis Phase 1 Clinical Trials
3. Ankylosing Spondylitis Epidemiology Analysis
4. US Ankylosing Spondylitis Market Insights: 4.1. Marketed Products for Ankylosing Spondylitis in US; 4.2. US Ankylosing Spondylitis Market Size & Forecast; 4.3. US Ankylosing Spondylitis Product Sales Forecast; 4.4. US Ankylosing Spondylitis Market Share Analysis
5. Germany Ankylosing Spondylitis Market Insights: 5.1. Marketed Products for Ankylosing Spondylitis in Germany; 5.2. Germany Ankylosing Spondylitis Market Size & Forecast; 5.3. Germany Ankylosing Spondylitis Product Sales Forecast; 5.4. Germany Ankylosing Spondylitis Market Share Analysis
6. France Ankylosing Spondylitis Market Insights: 6.1. Marketed Products for Ankylosing Spondylitis in France; 6.2. France Ankylosing Spondylitis Market Size & Forecast; 6.3. France Ankylosing Spondylitis Product Sales Forecast; 6.4. France Ankylosing Spondylitis Market Share Analysis
7. Italy Ankylosing Spondylitis Market Insights: 7.1. Marketed Products for Ankylosing Spondylitis in Italy; 7.2. Italy Ankylosing Spondylitis Market Size & Forecast; 7.3. Italy Ankylosing Spondylitis Product Sales Forecast; 7.4. Italy Ankylosing Spondylitis Market Share Analysis
8. Spain Ankylosing Spondylitis Market Insights: 8.1. Marketed Products for Ankylosing Spondylitis in Spain; 8.2. Spain Ankylosing Spondylitis Market Size & Forecast; 8.3. Spain Ankylosing Spondylitis Product Sales Forecast; 8.4. Spain Ankylosing Spondylitis Market Share Analysis
9. UK Ankylosing Spondylitis Market Insights: 9.1. Marketed Products for Ankylosing Spondylitis in UK; 9.2. UK Ankylosing Spondylitis Market Size & Forecast; 9.3. UK Ankylosing Spondylitis Product Sales Forecast; 9.4. UK Ankylosing Spondylitis Market Share Analysis
10. Europe Ankylosing Spondylitis Market Insights: 10.1. Europe Ankylosing Spondylitis Market Size & Forecast; 10.2. Europe Ankylosing Spondylitis Product Sales Forecast; 10.3. Europe Ankylosing Spondylitis Market Share Analysis
11. Japan Ankylosing Spondylitis Market Insights: 11.1. Marketed Products for Ankylosing Spondylitis in Japan; 11.2. Japan Ankylosing Spondylitis Market Size & Forecast; 11.3. Japan Ankylosing Spondylitis Product Sales Forecast; 11.4. Japan Ankylosing Spondylitis Market Share Analysis
12. Global Ankylosing Spondylitis Market Insights: 12.1. Global Ankylosing Spondylitis Market Size & Forecast; 12.2. Global Ankylosing Spondylitis Product Sales Forecast; 12.3. Global Ankylosing Spondylitis Market Share Analysis
13. Research Methodology
LIST OF TABLES: Table 1: Ankylosing Spondylitis Phase 3 Clinical Trials, Global, 2017; Table 2: Ankylosing Spondylitis Phase 2 Clinical Trials, Global, 2017; Table 3: Ankylosing Spondylitis Phase 1 Clinical Trials, Global, 2017; Table 4: Ankylosing Spondylitis Prevalence by G7 Countries, 2012 - 2021; Table 5: Marketed Products for Ankylosing Spondylitis in US, 2017; Table 6: US Ankylosing Spondylitis Market Size & Forecast ($mn), 2012 - 2021; Table 7: US Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Table 8: US Ankylosing Spondylitis Market Trends, 2012 - 2021; Table 9: Marketed Products for Ankylosing Spondylitis in Germany, 2017; Table 10: Germany Ankylosing Spondylitis Market Size & Forecast ($mn), 2012 - 2021; Table 11: Germany Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Table 12: Germany Ankylosing Spondylitis Market Trends, 2012 - 2021; Table 13: Marketed Products for Ankylosing Spondylitis in France, 2017; Table 14: France Ankylosing Spondylitis Market Size & Forecast ($mn), 2012 - 2021; Table 15: France Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Table 16: France Ankylosing Spondylitis Market Trends, 2012 - 2021; Table 17: Marketed Products for Ankylosing Spondylitis in Italy, 2017; Table 18: Italy Ankylosing Spondylitis Market Size & Forecast ($mn), 2012 - 2021; Table 19: Italy Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Table 20: Italy Ankylosing Spondylitis Market Trends, 2012 - 2021; Table 21: Marketed Products for Ankylosing Spondylitis in Spain, 2017; Table 22: Spain Ankylosing Spondylitis Market Size & Forecast ($mn), 2012 - 2021; Table 23: Spain Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Table 24: Spain Ankylosing Spondylitis Market Trends, 2012 - 2021; Table 25: Marketed Products for Ankylosing Spondylitis in UK, 2017; Table 26: UK Ankylosing Spondylitis Market Size & Forecast ($mn), 2012 - 2021; Table 27: UK Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Table 28: UK Ankylosing Spondylitis Market Trends, 2012 - 2021; Table 29: Europe Ankylosing Spondylitis Market Size & Forecast ($mn), 2012 - 2021; Table 30: Europe Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Table 31: Marketed Products for Ankylosing Spondylitis in Japan, 2017; Table 32: Japan Ankylosing Spondylitis Market Size & Forecast ($mn), 2012 - 2021; Table 33: Japan Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Table 34: Japan Ankylosing Spondylitis Market Trends, 2012 - 2021; Table 35: Global Ankylosing Spondylitis Market Size & Forecast ($mn), 2012 - 2021; Table 36: Global Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021
LIST OF FIGURES: Figure 1: Ankylosing Spondylitis Pipeline by Phase (%), Global, 2017; Figure 2: Ankylosing Spondylitis Prevalence by G7 Countries, 2012 - 2021; Figure 3: US Ankylosing Spondylitis Market Size ($mn), 2012 - 2021; Figure 4: US Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Figure 5: US Ankylosing Spondylitis Market Share by Products (%), 2016; Figure 6: US Ankylosing Spondylitis Market - Future Market Share (%), 2021; Figure 7: Germany Ankylosing Spondylitis Market Size ($mn), 2012 - 2021; Figure 8: Germany Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Figure 9: Germany Ankylosing Spondylitis Market Share by Products (%), 2016; Figure 10: Germany Ankylosing Spondylitis Market - Future Market Share (%), 2021; Figure 11: France Ankylosing Spondylitis Market Size ($mn), 2012 - 2021; Figure 12: France Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Figure 13: France Ankylosing Spondylitis Market Share by Products (%), 2016; Figure 14: France Ankylosing Spondylitis Market - Future Market Share (%), 2021; Figure 15: Italy Ankylosing Spondylitis Market Size ($mn), 2012 - 2021; Figure 16: Italy Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Figure 17: Italy Ankylosing Spondylitis Market Share by Products (%), 2016; Figure 18: Italy Ankylosing Spondylitis Market - Future Market Share (%), 2021; Figure 19: Spain Ankylosing Spondylitis Market Size ($mn), 2012 - 2021; Figure 20: Spain Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Figure 21: Spain Ankylosing Spondylitis Market Share by Products (%), 2016; Figure 22: Spain Ankylosing Spondylitis Market - Future Market Share (%), 2021; Figure 23: UK Ankylosing Spondylitis Market Size ($mn), 2012 - 2021; Figure 24: UK Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Figure 25: UK Ankylosing Spondylitis Market Share by Products (%), 2016; Figure 26: UK Ankylosing Spondylitis Market - Future Market Share (%), 2021; Figure 27: Europe Ankylosing Spondylitis Market Size ($mn), 2012 - 2021; Figure 28: Europe Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Figure 29: Europe Ankylosing Spondylitis Market Share by Products (%), 2016; Figure 30: Europe Ankylosing Spondylitis Market - Future Market Share (%), 2021; Figure 31: Japan Ankylosing Spondylitis Market Size ($mn), 2012 - 2021; Figure 32: Japan Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Figure 33: Japan Ankylosing Spondylitis Market Share by Products (%), 2016; Figure 34: Japan Ankylosing Spondylitis Market - Future Market Share (%), 2021; Figure 35: Global Ankylosing Spondylitis Market Size ($mn), 2012 - 2021; Figure 36: Global Ankylosing Spondylitis Product Sales ($mn), 2012 - 2021; Figure 37: Global Ankylosing Spondylitis Market Share by Products (%), 2016; Figure 38: Global Ankylosing Spondylitis Market - Future Market Share (%), 2021